This company has been marked as potentially delisted and may not be actively trading. Third Harmonic Bio (THRD) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock THRD vs. ZBIO, BGM, EYPT, PGEN, MNMD, SEPN, CRMD, DNA, FTRE, and KURAShould you be buying Third Harmonic Bio stock or one of its competitors? The main competitors of Third Harmonic Bio include Zenas BioPharma (ZBIO), BGM Group (BGM), Eyepoint Pharmaceuticals (EYPT), Precigen (PGEN), Mind Medicine (MindMed) (MNMD), Septerna (SEPN), CorMedix (CRMD), Ginkgo Bioworks (DNA), Fortrea (FTRE), and Kura Oncology (KURA). These companies are all part of the "med - biomed/gene" industry. Third Harmonic Bio vs. Its Competitors Zenas BioPharma BGM Group Eyepoint Pharmaceuticals Precigen Mind Medicine (MindMed) Septerna CorMedix Ginkgo Bioworks Fortrea Kura Oncology Zenas BioPharma (NASDAQ:ZBIO) and Third Harmonic Bio (NASDAQ:THRD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Is ZBIO or THRD more profitable? Third Harmonic Bio's return on equity of -19.27% beat Zenas BioPharma's return on equity.Company Net Margins Return on Equity Return on Assets Zenas BioPharmaN/A -59.21% -50.56% Third Harmonic Bio N/A -19.27%-18.67% Does the media favor ZBIO or THRD? In the previous week, Zenas BioPharma had 49 more articles in the media than Third Harmonic Bio. MarketBeat recorded 49 mentions for Zenas BioPharma and 0 mentions for Third Harmonic Bio. Zenas BioPharma's average media sentiment score of 0.46 beat Third Harmonic Bio's score of 0.00 indicating that Zenas BioPharma is being referred to more favorably in the media. Company Overall Sentiment Zenas BioPharma Neutral Third Harmonic Bio Neutral Which has better valuation and earnings, ZBIO or THRD? Third Harmonic Bio has lower revenue, but higher earnings than Zenas BioPharma. Third Harmonic Bio is trading at a lower price-to-earnings ratio than Zenas BioPharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZenas BioPharma$5M223.52-$156.99M-$3.55-7.48Third Harmonic BioN/AN/A-$45.47M-$0.62-8.68 Do insiders and institutionals have more ownership in ZBIO or THRD? 94.0% of Third Harmonic Bio shares are owned by institutional investors. 16.5% of Zenas BioPharma shares are owned by company insiders. Comparatively, 7.8% of Third Harmonic Bio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Do analysts prefer ZBIO or THRD? Zenas BioPharma presently has a consensus target price of $38.33, suggesting a potential upside of 44.44%. Third Harmonic Bio has a consensus target price of $5.00, suggesting a potential downside of 7.06%. Given Zenas BioPharma's stronger consensus rating and higher possible upside, equities research analysts plainly believe Zenas BioPharma is more favorable than Third Harmonic Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zenas BioPharma 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Third Harmonic Bio 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryZenas BioPharma beats Third Harmonic Bio on 7 of the 12 factors compared between the two stocks. Get Third Harmonic Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for THRD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding THRD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart THRD vs. The Competition Export to ExcelMetricThird Harmonic BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$242.80M$3.33B$6.04B$10.46BDividend YieldN/A2.31%5.73%4.79%P/E Ratio-4.3722.2285.3127.07Price / SalesN/A445.29591.31190.92Price / CashN/A44.9825.7330.17Price / Book0.8510.3812.666.69Net Income-$45.47M-$52.31M$3.31B$276.03M Third Harmonic Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)THRDThird Harmonic BioN/A$5.38flat$5.00-7.1%N/A$242.80MN/A-4.37N/AZBIOZenas BioPharma2.2265 of 5 stars$20.85-9.5%$36.67+75.9%N/A$969.80M$5M-5.87N/AAnalyst RevisionBGMBGM Group0.5591 of 5 stars$9.69-2.1%N/A+29.9%$962.98M$25.10M0.00298Gap DownEYPTEyepoint Pharmaceuticals1.4683 of 5 stars$13.25-2.7%$26.86+102.7%+53.7%$938.79M$43.27M-4.94120PGENPrecigen4.4718 of 5 stars$3.31+5.4%$8.25+149.2%+247.2%$935.64M$3.92M-7.88190MNMDMind Medicine (MindMed)2.4622 of 5 stars$11.97-2.0%$26.50+121.4%+118.3%$929.79MN/A-7.8240Analyst ForecastGap UpSEPNSepterna0.8456 of 5 stars$21.01+1.0%$26.75+27.3%N/A$927.37M$1.08M-2.08N/ACRMDCorMedix2.8246 of 5 stars$11.09-4.1%$18.00+62.3%+6.0%$902.36M$43.47M14.7930Analyst DowngradeDNAGinkgo Bioworks1.1778 of 5 stars$14.81-0.4%$9.00-39.2%+84.4%$880.30M$230.82M-2.53640Gap UpFTREFortrea3.2051 of 5 stars$9.31-2.9%$11.72+25.9%-48.9%$870.77M$2.70B-0.8215,500Analyst DowngradeGap UpKURAKura Oncology4.0632 of 5 stars$9.43-3.8%$24.10+155.6%-47.0%$850.61M$53.88M-4.17130 Related Companies and Tools Related Companies Zenas BioPharma Competitors BGM Group Competitors Eyepoint Pharmaceuticals Competitors Precigen Competitors Mind Medicine (MindMed) Competitors Septerna Competitors CorMedix Competitors Ginkgo Bioworks Competitors Fortrea Competitors Kura Oncology Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:THRD) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Third Harmonic Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Third Harmonic Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
